Nguyen Y, Sibley L, Przanowski P, Zhao X, Kovacs M, Wang S
J Neuroimmunol. 2024; 393:578402.
PMID: 38996717
PMC: 11318612.
DOI: 10.1016/j.jneuroim.2024.578402.
Uzelac A, Klun I, Djurkovic-Djakovic O
Front Cell Infect Microbiol. 2024; 14:1414067.
PMID: 38912206
PMC: 11190176.
DOI: 10.3389/fcimb.2024.1414067.
Nayeri T, Sarvi S, Daryani A
Heliyon. 2024; 10(10):e31558.
PMID: 38818168
PMC: 11137575.
DOI: 10.1016/j.heliyon.2024.e31558.
Arruda I, Amendoeira M, Bonifacio T, Raso C, Elidio H, Coelho J
Animals (Basel). 2024; 14(9).
PMID: 38731332
PMC: 11083367.
DOI: 10.3390/ani14091326.
Rojas-Baron L, Hermosilla C, Taubert A, Velasquez Z
Front Microbiol. 2024; 15:1336267.
PMID: 38450167
PMC: 10915083.
DOI: 10.3389/fmicb.2024.1336267.
Susceptibility of to autophagy in human cells relies on multiple interacting parasite loci.
Rinkenberger N, Rosenberg A, Radke J, Bhushan J, Tomita T, Weiss L
mBio. 2023; 15(1):e0259523.
PMID: 38095418
PMC: 10790690.
DOI: 10.1128/mbio.02595-23.
Mode of action studies confirm on-target engagement of lysyl-tRNA synthetase inhibitor and lead to new selection marker for .
Hanna J, Corpas-Lopez V, Seizova S, Colon B, Bacchetti R, Hall G
Front Cell Infect Microbiol. 2023; 13:1236814.
PMID: 37600947
PMC: 10436570.
DOI: 10.3389/fcimb.2023.1236814.
Variation in CD8 T cell IFNγ differentiation to strains of is characterized by small effect QTLs with contribution from ROP16.
Kongsomboonvech A, Garcia-Lopez L, Njume F, Rodriguez F, Souza S, Rosenberg A
Front Cell Infect Microbiol. 2023; 13:1130965.
PMID: 37287466
PMC: 10242045.
DOI: 10.3389/fcimb.2023.1130965.
Effects of Ovine Monocyte-Derived Macrophage Infection by Recently Isolated Strains Showing Different Phenotypic Traits.
Vallejo R, Benavides J, Arteche-Villasol N, Fernandez-Escobar M, Ferreras M, Perez V
Animals (Basel). 2022; 12(24).
PMID: 36552372
PMC: 9774764.
DOI: 10.3390/ani12243453.
Changes of gut microbiota structure in rats infected with .
Lv Q, Ma H, Wei J, Qin Y, Qiu H, Ni H
Front Cell Infect Microbiol. 2022; 12:969832.
PMID: 35967867
PMC: 9366923.
DOI: 10.3389/fcimb.2022.969832.
Unifying Virulence Evaluation in : A Timely Task.
Calero-Bernal R, Fernandez-Escobar M, Katzer F, Su C, Ortega-Mora L
Front Cell Infect Microbiol. 2022; 12:868727.
PMID: 35573788
PMC: 9097680.
DOI: 10.3389/fcimb.2022.868727.
Ocular toxoplasmosis: a review of the current diagnostic and therapeutic approaches.
Kalogeropoulos D, Sakkas H, Mohammed B, Vartholomatos G, Malamos K, Sreekantam S
Int Ophthalmol. 2021; 42(1):295-321.
PMID: 34370174
PMC: 8351587.
DOI: 10.1007/s10792-021-01994-9.
In vivo and in vitro models show unexpected degrees of virulence among Toxoplasma gondii type II and III isolates from sheep.
Fernandez-Escobar M, Calero-Bernal R, Regidor-Cerrillo J, Vallejo R, Benavides J, Collantes-Fernandez E
Vet Res. 2021; 52(1):82.
PMID: 34112256
PMC: 8194156.
DOI: 10.1186/s13567-021-00953-7.
An atypical case of neurotoxoplasmosis in immunocompetent patient.
Lima K, Luiz Guimaraes de Queiroz A, Teixeira H, Bonsi V, Inada B, Lancellotti C
Radiol Case Rep. 2021; 16(7):1766-1769.
PMID: 34007399
PMC: 8111245.
DOI: 10.1016/j.radcr.2021.04.013.
Reevaluation of the and genomes reveals misassembly, karyotype differences, and chromosomal rearrangements.
Berna L, Marquez P, Cabrera A, Greif G, Francia M, Robello C
Genome Res. 2021; 31(5):823-833.
PMID: 33906964
PMC: 8092007.
DOI: 10.1101/gr.262832.120.
Third-generation sequencing revises the molecular karyotype for and identifies emerging copy number variants in sexual recombinants.
Xia J, Venkat A, Bainbridge R, Reese M, Le Roch K, Ay F
Genome Res. 2021; 31(5):834-851.
PMID: 33906962
PMC: 8092015.
DOI: 10.1101/gr.262816.120.
In Vivo and In Vitro Virulence Analysis of Four Genetically Distinct Lineage III Isolates.
Uzelac A, Klun I, Cirkovic V, Djurkovic-Djakovic O
Microorganisms. 2020; 8(11).
PMID: 33142663
PMC: 7693757.
DOI: 10.3390/microorganisms8111702.
The molecular biology and immune control of chronic Toxoplasma gondii infection.
Zhao X, Ewald S
J Clin Invest. 2020; 130(7):3370-3380.
PMID: 32609097
PMC: 7324197.
DOI: 10.1172/JCI136226.
Optimizing Pyrazolopyrimidine Inhibitors of Calcium Dependent Protein Kinase 1 for Treatment of Acute and Chronic Toxoplasmosis.
Janetka J, Hopper A, Yang Z, Barks J, Dhason M, Wang Q
J Med Chem. 2020; 63(11):6144-6163.
PMID: 32420739
PMC: 7325724.
DOI: 10.1021/acs.jmedchem.0c00419.
effector TgIST blocks type I interferon signaling to promote infection.
Matta S, Olias P, Huang Z, Wang Q, Park E, Yokoyama W
Proc Natl Acad Sci U S A. 2019; 116(35):17480-17491.
PMID: 31413201
PMC: 6717281.
DOI: 10.1073/pnas.1904637116.